Regulation of the estrogen-responsive pS2 gene in MCF-7 human breast cancer cells

Journal of Steroid Biochemistry and Molecular Biology

Volumn 74, Issue 4, 2000, Pages 157-168

  Kim, Jongsook ^a   Petz, Larry N ^a   Ziegler, Yvonne S ^a   Wood, Jennifer R ^a   Potthoff, Sara J ^b   Nardulli, Ann M ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Antiestrogen; Chromatin; Estrogen; Transcription

Indexed keywords

4 HYDROXYTAMOXIFEN; ANTIESTROGEN; DEOXYRIBONUCLEASE I; DIMETHYL SULFATE; DNA FRAGMENT; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FULVESTRANT; LYSOPHOSPHATIDYLCHOLINE; MESSENGER RNA; NUCLEAR PROTEIN; PROTEIN PS2; TRITON X 114;

ARTICLE; BREAST CARCINOMA; CHROMATIN; CONTROLLED STUDY; DNA FLANKING REGION; DNA FOOTPRINTING; DRUG MECHANISM; ESTROGEN RESPONSIVE ELEMENT; GENE TARGETING; HUMAN; HUMAN CELL; PROMOTER REGION; PROTEIN DNA INTERACTION; TATA BOX; TRANSCRIPTION REGULATION;

BREAST NEOPLASMS; DEOXYRIBONUCLEASE I; DNA; DNA FOOTPRINTING; ESTRADIOL; ESTROGEN RECEPTOR MODULATORS; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); PROTEINS; RESPONSE ELEMENTS; TAMOXIFEN; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0034668704     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(00)00119-9     Document Type: Article

References (66)

1. Steroid hormone receptors: Many actors in search of a plot
2. Cloning of a novel estrogen receptor expressed in rat prostate and ovary
3. ERβ: Identification and characterization of a novel human estrogen receptor
4. Specific expression of the pS2 gene in subclasses of breast cancers in comparison with expression of the estrogen and progesterone receptors and the oncogene ERBB2
5. Sequence of the pS2 mRNA induced by estrogen in the human breast cancer cell line MCF-7
6. Structure of the human oestrogen-responsive gene pS2
7. Characterization of the estrogen-induced pS2 protein secreted by the human breast cancer cell line MCF-7
8. Activation of pS2 gene transcription is a primary response to estrogen in the human breast cancer cell line MCF-7
9. Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line
10. The 5′ flanking region of the pS2 gene contains a complex enhancer region responsive to oestrogens, epidermal growth factor, a tumour promoter (TPA), the c-Ha-ras oncoprotein and the c-jun protein
11. Evaluation of tamoxifen dose in advanced breast cancer: A progress report
12. pS2 expression and response to hormonal therapy in patients with advanced breast cancer
13. Prediction of relapse and survival in breast cancer patients by pS2 protein status
14. Progression of human breast cancer cells from hormone-dependent to hormone-independent growth both in vitro and in vivo
15. Effects of estrogens and antiestrogens on estrogen receptor dynamics and the induction of progesterone receptor in MCF-7 breast cancer cells
16. Multihormonal regulation of the progesterone receptor in MCF-7 human breast cancer cells: Interrelationships among insulin/insulin-like growth factor-I, serum, and estrogen
17. Progesterone receptor regulation in T47D human breast cancer cells: Analysis by density labeling of progesterone receptor synthesis and degradation and their modulation by progestin
18. p300 and estrogen receptor cooperatively activate transcription via differential enhancement of initiation and reinitiation
19. Ligation-mediated PCR for genomic sequencing and footprinting
20. An improved protocol for genomic sequencing and footprinting by ligation-mediated PCR
21. Purified estrogen receptor DNA binding domain expressed in Escherichia coli activates transcription of an estrogen-responsive promoter in cultured cells
22. DNA bending is induced by binding of the glucocorticoid receptor DNA binding domain and progesterone receptor to their response element
23. Mobility shift DNA-binding assay using gel electrophoresis
24. Regulation of pS2 gene expression by affinity labeling and reversibly binding estrogens and antiestrogens: Comparison of effects on the native gene and on pS2-chloramphenicol acetyltransferase fusion genes transfected into MCF-7 human breast cancer cells
25. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 Randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women
26. Are breast tumours resistant to tamoxifen also resistant to pure antioestrogens?
27. Investigation of a new pure antiestrogen (ICI 182,780) in women with primary breast cancer
28. Estrogen-responsive element of the human pS2 gene is an imperfectly palindromic sequence
29. Comparison of the effects of a pure steroidal antiestrogen with those of tamoxifen in a model of human breast cancer
30. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β
31. Members of the steroid hormone receptor superfamily interact with TFIIB (S300-II)
32. Different TBP-associated factors are required for mediating the stimulation of transcription in vitro by the acidic transactivator GAL-VP16 and the two non-acidic activation functions of the estrogen receptor
33. Human TAFII30 is present in a distinct TFIID complex and is required for transcriptional activation by the estrogen receptor
34. Transcriptional activators differ in their responses to overexpression of TATA-box-binding protein
35. DNA recognition by DNase I
36. Nucleosome positioning and transcription-associated chromatin alterations on the human estrogen-responsive pS2 promoter
37. Human estrogen receptor bound to an estrogen response element bends DNA
38. Estrogen receptor-induced bending of the Xenopus vitellogenin A2 gene hormone response element
39. Estrogen receptor-induced DNA bending: Orientation of the bend and replacement of an estrogen response element with an intrinsic DNA bending sequence
40. Estrogen receptor affinity and location of consensus and imperfect estrogen response elements influence transcription activation of simplified promoters
41. Tissue-specific and steroid-dependent interaction of transcription factors with the oestrogen-inducible apoVLDL II promoter in vivo
42. Estrogen-dependent transcriptional activation and vitellogenin gene memory
43. In vivo protein-DNA interactions in a glucocorticoid response element require the presence of the hormone
44. Glucocorticoids are required for establishment and maintenance of an alteration in chromatin structure: Induction leads to a reversible disruption of nucleosomes over an enhancer
45. Chromatin structure of the MMTV promoter and its changes during hormonal induction
46. In vivo genomic footprinting of thyroid hormone-responsive genes in pituitary tumor cell lines
47. Ligand-dependent occupancy of the retinoic acid receptor β2 promoter in vivo
48. In vivo footprinting of rat TAT gene: Dynamic interplay between the glucocorticoid receptor and a liver-specific factor
49. In vivo footprinting of an androgen-dependent enhancer reveals an accessory element integral to hormone response
50. Dissection of progesterone receptor-mediated chromatin remodeling and transcriptional activation in vivo
51. Tamoxifen for prevention of breast cancer: Report of the national surgical adjuvant breast and bowel project P-1 study
52. Response to a specific antioestrogen (ICI 182,780) in tamoxifen-resistant breast cancer
53. Mechanisms of antihormone action
54. MCF7/LCC2: A 4-hydroxytamoxifen resistant human breast cancer variant the retains sensitivity to the steroidal antiestrogen ICI 182,780
55. A potent specific pure antiestrogen with clinical potential
56. Transcriptional activation by the estrogen receptor requires a conformational change in the ligand binding domain
57. Conformational transitions of the estrogen receptor monomer
58. A ligand-induced conformational change in the estrogen receptor is localized in the steroid binding domain
59. Molecular basis of agonism and antagonism in the oestrogen receptor
60. Mechanism of estrogen receptor-dependent transcription in a cell-free system
61. Crystal structure of a yeast TBP/TATA-box complex
62. Nuclear receptor coativators and corepressors
63. A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression
64. Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase
65. What's up and down with histone deacetylation and transcription?
66. Steroid receptor coactivator-1 is a histone acetyltransferase